How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity medications.

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.

Florey researchers have engineered a way to fool the immune system into accepting neural grafts as part of the body, rather ...

Israeli researchers said Friday they have developed a simple, "revolutionary" blood test that for the first time would allow ...

risks of GLP-1 weight-loss drugs GLP-1 medications show promise in slowing kidney disease progression Cosmetic surgeons try to correct 'Ozempic face' for weight-loss drug users GLP-1 drugs mimic ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced risk of Alzheimer’s disease and related dementias (ADRD).

"We're excited by the emerging data from our GLP toxicology study ... Visit us at www.capsida.com. 1 Leyns, C. E, G. et al (2023). npj Parkinson's Disease, 74(9).